M. Possanzini

Centro Diagnostico Italiano

Papers

2

Total Citations

120

H-Index

2

About

M. Possanzini is a leading figure in the field of radiation oncology, with a focused expertise in the salvage treatment of recurrent prostate cancer. Their research has been pivotal in advancing the use of stereotactic body radiotherapy (SBRT) and robotic radiosurgery for managing isolated lymph node and locally recurrent disease after primary treatment failure. Possanzini’s major contributions include demonstrating the feasibility and safety of reirradiation using the CyberKnife system, as evidenced by their landmark 2009 study on linac-based and robotic image-guided stereotactic radiotherapy for isolated lymph node recurrences (71 citations) and a subsequent 2010 feasibility study on salvage therapy for locally recurrent prostate cancer (49 citations). These works have helped establish a non-invasive, high-precision alternative to more aggressive salvage therapies, offering patients a potentially lower-toxicity option. By systematically evaluating dose delivery and clinical outcomes, Possanzini has provided critical evidence supporting the integration of image-guided radiosurgery into the salvage treatment paradigm, influencing clinical protocols and inspiring further investigation into SBRT for oligometastatic disease.

Research Focus

Key Achievements

2
H-Index
2
Papers
120
Total Citations
60
Avg Citations/Paper
🏆 Most Cited Paper
Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer
71 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Centro Diagnostico Italiano

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago